GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan · Delayed Price · Currency is PKR 392.43
-3.90 (-0.98%)
At close: Jul 18, 2025
GlaxoSmithKline Pakistan Market Cap
GlaxoSmithKline Pakistan has a market cap or net worth of 124.98 billion as of July 18, 2025. Its market cap has increased by 172.82% in one year.
Market Cap
124.98B
Enterprise Value
119.15B
Revenue
61.15B
Ranking
n/a
PE Ratio
15.43
Stock Price
392.43
Market Cap Chart
Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 124.98B, an increase of 3,214.27%. That is a compound annual growth rate of 12.03%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott Laboratories (Pakistan) | 107.65B |
| Highnoon Laboratories | 57.46B |
| AGP Limited | 56.25B |
| The Searle Company | 49.13B |
| Shifa International Hospitals | 34.71B |
| Citi Pharma | 19.19B |
| Ferozsons Laboratories | 17.13B |
| Otsuka Pakistan | 3.44B |